Nxstage Medical Uk, Ltd.
07857151
Healthy
- Loss before tax (-10)
- Going concern doubt noted in accounts (-10)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 24/07/2023
CHIEF FINANCIAL OFFICER
BRITISH · UNITED KINGDOM · Age 44
Also on 7 other boards
director · Since 24/07/2023
MANAGING DIRECTOR - COMMERCIAL OPERATION
BRITISH · UNITED KINGDOM · Age 44
Also on 7 other boards
director · Since 02/06/2025
LAWYER
BRITISH · UNITED KINGDOM · Age 58
Also on 1 other board
Persons with Significant Control
Fresenius Medical Care (Holdings) Limited
Nunn Brook Road, Huthwaite, Sutton-In-Ashfield, NG17 2HU
Reg: 03218090 · Companies House Of England And Wales · Private Company Limited By Shares
Notified 01/09/2023
Former PSCs
Nxstage Medical, Inc.
Ceased 01/09/2023
CompanyRankvs 5086+ SIC 82990 peers75
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the directors with respect to going co
Key FinancialsYear ending 31/12/2024
Turnover
£8.9M
Annual revenue
Net Worth
£2.8M
Balance sheet strength
Cash
£54k
Cash in the bank
Profit Before Tax
-£246k
Bottom line earnings
Net Current Assets
—
Working capital
Current Assets
£2.8M
Current Liabilities
£16k
Debtors
£2.8M
Cost of Sales
£10k
Gross Profit
-£10k
Admin Expenses
£205k
Operating Profit
-£215k
Profit After Tax
-£246k
Tax at Year End
People Costs(2021)
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 176.11 | -£246k |
| 2023 | 1.87 | +£144k |
| 2021 | 0.61 | — |
Derived from filed accounts. Not audited figures.